Methylprednisolone Completed Phase 2 Trials for Bursitis Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01205477Safety and Efficacy of Methylprednisolone Infiltration in Anserine Bursitis Treatment